CFTC-regulated INJ futures launch drives Injective higher

Traders Union
All News
Crypto News
Injective jumps 9.33% to $5.05 today

Highlights

Injective has burned over 6.87 million INJ through ongoing protocol buybacks, intensifying token scarcity and supporting demand.
USDC integration and CFTC-regulated INJ futures are expanding access and liquidity, while new partnerships boost pre-IPO trading functions.
INJ trades above key supports, but overbought signals and volatility suggest consolidation between $4.80 and $5.60 in the near term.

Scarcity and liquidity support buying as supply shrinks and integrations expand

Ongoing protocol-level buybacks and burns have permanently removed more than 6.87 million INJ from circulation, highlighted by a sizable community event on May 6 that eliminated over $196,000 in ecosystem revenue within minutes. This sustained reduction in available supply, initiated by Injective's Supply Squeeze Upgrade passed in January 2026, continues to drive scarcity and support buying interest. Secondary drivers include the seamless integration of Circle’s USDC on the Injective blockchain and the arrival of CFTC-regulated INJ futures in the U.S., both of which expand access and deepen liquidity, while a partnership with Republic introduces new functionality for retail trading in pre-IPO markets.

Bullish momentum holds as oscillators near overbought levels

SMA-20 is at $4.25, SMA-50 at $3.58, and SMA-200 at $4.35, all below current levels. The Ichimoku Kijun sits at $4.68, serving as immediate support, while the current price is near the lower end of today’s volatile range ($5.04–$5.43) after a gap up from $4.62 to $5.16. Momentum remains strong: daily ADX and MACD confirm positive trend strength, and Bull/Bear Power (BBP) at 0.49 suggests buyers are in control. However, RSI at 69.6 and CCI at 83.8 are nearing overbought territory. The Stoch RSI indicates strong buy momentum but is not yet at extreme readings. Emerging hesitation is visible as oscillators approach overheated conditions, hinting at a potential short-term pullback or consolidation.

Upside capped as consolidation expected amid fading buying pressure

In the next five trading days, expected price action is likely to remain within a volatility band ranging from $4.80 to $5.60. The probability of a further upside move is low, with less than a 20% chance for a break above $5.60 unless buying pressure unexpectedly intensifies. The baseline scenario is consolidation, with INJ stabilizing between the Kijun and upper resistance, while a breakdown could see the price fall back toward $4.80 support if buying momentum fades and profit-taking accelerates.

Anton Kharitonov, expert at Traders Union, sees sustained protocol buybacks and burns as a significant factor underpinning current price strength. He notes that trading remains above key technical levels, but momentum indicators signal a possible near-term pause. The analyst remains cautious given the proximity to overbought readings and narrowing volatility. "For now, I expect consolidation in the $4.80 to $5.60 band, and will reassess if support at $4.80 fails or buying pressure clearly resumes."

Earlier, analysts noted that Injective's outlook remained cautious amid persistent bearish indicators and supply-side constraints, with price action largely confined to a sideways trend. The current rally above major moving averages, underpinned by intensified buybacks and ecosystem expansion, introduces early signs of a potential trend shift, making the sustainability of buying momentum above the $5.60 resistance a key risk to monitor in the near term.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.